Anti-Marijuana Groups And Pharma Company Ask Court To Revive Lawsuit Challenging Medicare Hemp Coverage Program
Anti-marijuana advocacy groups and a cannabis-focused biopharmaceutical company have filed an appeal challenging a federal judge's dismissal of their lawsuit against a Trump administration Medicare program that would provide up to $500 annual coverage for hemp-derived products to eligible beneficiaries. Judge Trevor N. McFadden had previously dismissed the legal challenge, and the coalition is now seeking reversal in federal appeals court.
Filed under Court Ruling in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
RFK And Dr. Oz Want Anti-Marijuana Groups’ Lawsuit Challenging Medicare Hemp Coverage Program Dismissed
Anti-Marijuana Groups File Lawsuit To Block Trump Administration’s Hemp CBD And THC Medicare Coverage Plan
Judge Rejects Anti-Marijuana Groups’ Motion To Block CBD And THC Medicare Coverage Plan, Setting Hearing For 4/20
Feds sued over Medicare cannabis product coverage (Newsletter: April 1, 2026)
Trump Pushes Congress To Keep Full-Spectrum CBD Legal While Restricting Hemp Products That Pose ‘Health Risks’
Ellison and other AGs push for ban on ‘intoxicating hemp-derived’ THC products
Stay current on Minnesota cannabis
Browse more court ruling updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.